Molecular subtyping and insights into sarcoma biology and prognosis. Log10 change in ctDNA from baseline at end of cycle 1 and cycle 2 chemotherapy by initial imaging response. Initial Response Cycle ...

There has been growing interest in the use of real-world data (RWD) to address clinically and policy-relevant (research) questions that cannot be answered with data from randomized controlled trials ...

This article first appeared with Targeted Oncology ™. An orphan drug designation (ODD) was granted by the FDA to elraglusib for the treatment of patients with soft tissue sarcoma (STS). 1 Currently, a ...

A tumor is an abnormal mass of tissue that forms when cells grow and divide more than they should, or do not die when they should. Tumors may be benign ...